Novo Nordisk A/S (NONOF)
OTCMKTS · Delayed Price · Currency is USD
58.60
-2.40 (-3.93%)
Oct 9, 2025, 3:56 PM EDT
Novo Nordisk Market Cap
Novo Nordisk has a market cap or net worth of $261.06 billion as of October 9, 2025. Its market cap has decreased by -53.60% in one year.
Market Cap
261.06B
Enterprise Value
273.49B
Revenue
49.11B
Ranking
n/a
PE Ratio
14.93
Stock Price
$58.60
Market Cap Chart
Since February 18, 1997, Novo Nordisk's market cap has increased from 7.15B to 261.06B, an increase of 3,552.94%. That is a compound annual growth rate of 13.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2025 | 265.74B | -31.12% |
| Dec 30, 2024 | 385.82B | -16.41% |
| Dec 29, 2023 | 461.55B | 51.61% |
| Dec 30, 2022 | 304.43B | 19.34% |
| Dec 30, 2021 | 255.09B | 56.58% |
| Dec 30, 2020 | 162.91B | 19.30% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 674.12M |
| Glass House Brands | 644.95M |
| Veradigm | 511.83M |
| Northwest Biotherapeutics | 380.49M |
| Nika Pharmaceuticals | 333.67M |
| CytoDyn | 314.22M |
| American Oncology Network | 273.17M |
| Silence Therapeutics | 245.14M |